Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ear Protective Devices × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 2768 Cisplatin 2753 Carboplatin 2551 Radiotherapy 2455 Paclitaxel 2340 Gemcitabine 2196 pembrolizumab 2047 Docetaxel 1924 Bevacizumab 1892 Fluorouracil 1603 Capecitabine 1595 Oxaliplatin 1494 Dexamethasone 1378 Nivolumab 1348 Doxorubicin 1300 Rituximab 1291 Magnetic Resonance Spectroscopy 1193 Etoposide 1161 Irinotecan 1077 Leucovorin 1062 Drug Therapy 1033 Cytarabine 993 fludarabine 922 Pemetrexed 912 Specimen Handling 852 Vincristine 822 Lenalidomide 819 Prednisone 812 Cetuximab 811 Trastuzumab 810

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04609982 2024-08-21

SSNHL in Head & Neck Cancer Patients

Nova Scotia Health Authority

Phase NA Withdrawn

Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡